These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Correlations of alkylating activity and mutagenicity in bacteria of cytostatic drugs. Hemminki K; Kallama S; Falck K Acta Pharmacol Toxicol (Copenh); 1983 Nov; 53(5):421-8. PubMed ID: 6659971 [TBL] [Abstract][Full Text] [Related]
3. A COMPARISON OF EFFECTS OF SOME CHEMOTHERAPEUTIC AGENTS AND THOSE OF X-RAYS ON THE REPRODUCTIVE CAPACITY OF MAMMALIAN CELLS. BERRY RJ Nature; 1964 Sep; 203():1150-3. PubMed ID: 14213665 [No Abstract] [Full Text] [Related]
4. Reactions of nitrogen mustards with DNA. Hemminki K; Kallama S IARC Sci Publ; 1986; (78):55-70. PubMed ID: 3583398 [TBL] [Abstract][Full Text] [Related]
5. [Side-effects of cytostatic and immunosuppressive therapy]. Hartwich G Fortschr Med; 1973 Mar; 91(9):357-62. PubMed ID: 4633019 [No Abstract] [Full Text] [Related]
6. Adsorption to human red blood cells of chlorambucil and other biological alkylating agents. Linford JH; Hryniuk W; Israels LG Biochem Pharmacol; 1969 Oct; 18(10):2723-35. PubMed ID: 5404005 [No Abstract] [Full Text] [Related]
8. [Immunodepressant activity of certain radiomimetics in immunization of mice with sheep erythrocytes]. Kazarian KA Biull Eksp Biol Med; 1970 Mar; 69(3):87-91. PubMed ID: 4994633 [No Abstract] [Full Text] [Related]
9. Pharmacokinetics of alkylating agents. Lind MJ; Ardiet C Cancer Surv; 1993; 17():157-88. PubMed ID: 8137340 [TBL] [Abstract][Full Text] [Related]
11. [ON THE POSSIBILITY OF PROLONGING THE VIABILITY OF SKIN TRANSPLANTS IN RABBITS WITH ALKYLATING SUBSTANCES]. POPOV VI; NEZDATNYI MM Patol Fiziol Eksp Ter; 1964; 8():37-9. PubMed ID: 14184390 [No Abstract] [Full Text] [Related]
12. Comparative antitumor effects of peptichemio and other alkylating agents. Schmid FA; Banks SE; Stock CC Cancer Treat Rep; 1977; 61(3):473-5. PubMed ID: 872145 [No Abstract] [Full Text] [Related]
13. [Quantitative determination of alkylating cytostatics on TLC plate with 4-pyridinecarboxaldehyde-2-benzothiazolylhydrazone]. Norpoth K; Addicks HW; Witting U Arzneimittelforschung; 1973 Nov; 23(11):1529-35. PubMed ID: 4801657 [No Abstract] [Full Text] [Related]
14. [The hypoplastic state of hematopoiesis following chemotherapy with alkylating compounds]. Kholodnyi MD; Mindlin SS Vopr Onkol; 1969; 15(8):27-32. PubMed ID: 4982329 [No Abstract] [Full Text] [Related]
15. Survival of hematopoietic and lymphoma colony-forming cells in vivo following the administration of a variety of alkylating agents. Valeriote FA; Tolen SJ Cancer Res; 1972 Mar; 32(3):470-6. PubMed ID: 4621955 [No Abstract] [Full Text] [Related]
16. [Structure and mode of action of alkylating agents used in the therapy of neoplastic diseases]. Borresen HC Nord Med; 1969 Jan; 81(3):65-72. PubMed ID: 5767356 [No Abstract] [Full Text] [Related]
17. NEW AND OLD DRUGS IN THE MANAGEMENT OF HODGKIN'S DISEASE. SAMPEY JR Med Times; 1964 Jun; 92():571-4. PubMed ID: 14147083 [No Abstract] [Full Text] [Related]
18. THE TREATMENT OF CARCINOMA IN DOGS' BLADDERS WITH CYTOTOXIC DRUGS. BOYLAND E; KINDER CH; WILLIAMS K Invest Urol; 1965 Mar; 2():446-52. PubMed ID: 14261785 [No Abstract] [Full Text] [Related]
19. [THE REDUCTION OF RADIOPHOSPHORUS 32 INCORPORATION INTO CANCER CELLS BY NONTOXIC DOSES OF CYTOSTATIC SUBSTANCES]. KREPSZ I; PUPP A; GYERGYAY F Radiobiol Radiother (Berl); 1963; 4():479-82. PubMed ID: 14120270 [No Abstract] [Full Text] [Related]
20. On the biological alkylating agents. Haddow A Perspect Biol Med; 1973; 16(4):503-24. PubMed ID: 4593768 [No Abstract] [Full Text] [Related] [Next] [New Search]